Background: Assessment of treatment response to pulmonary tuberculosis (TB) is currently done by follow-up cultures since smear microscopy cannot distinguish viable from nonviable bacilli. This delays the therapeutic decision and increases the work load on the TB laboratories. This study evaluated the utility of fluorescein diacetate (FDA) viability staining against culture as a modal... https://www.elphonsolam.com/product-category/dimensional-wall-art/